## CTSH: Cognizant Technology Solutions Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.47 indicates fundamental undervaluation. Quality metrics strong (ROA 10%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-4.1% MRS), overbought RSI (80).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($81.68)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Microsoft Corporation (MSFT) and Cognizant Announce a Multi-Year Partnership**
- Source: Insider Monkey | 20251221T152233 | Somewhat-Bullish | Relevance: 93%
- Microsoft Corporation (NASDAQ: MSFT) and Cognizant have formed a multi-year partnership to provide AI-powered solutions to enterprises in healthcare, life sciences, retail, financial services, and manufacturing. This collaboration aims to embed agentic AI and Copilot into workflows to improve operational resilience, productivity, and customer experience, expanding on Cognizant's Neuro AI Suite. Additionally, Microsoft recently received a reiterated "Buy" rating and a $640.00 price target from Mizuho Securities.

**2. Zacks Industry Outlook Highlights Vertiv, Cognizant Technology Solutions and EPAM Systems**
- Source: The Globe and Mail | 20251223T021145 | Somewhat-Bullish | Relevance: 92%
- The Zacks Computers â€“ IT Services industry, including Vertiv, Cognizant Technology Solutions, and EPAM Systems, is benefiting from global digitization and robust spending on cloud, AI, and cybersecurity. Despite macroeconomic challenges, improving IT spending and the demand for hybrid work solutions are driving growth. Vertiv, Cognizant, and EPAM are highlighted as "Buy" opportunities due to their strong product portfolios, AI investments, and strategic acquisitions aiding growth.

**3. Microsoft Corporation (MSFT) and Cognizant Announce a Multi-Year Partnership**
- Source: Finviz | 20251221T150332 | Somewhat-Bullish | Relevance: 71%
- Microsoft Corporation (MSFT) and Cognizant have formed a multi-year partnership to help enterprises in sectors like healthcare, retail, and financial services leverage AI-powered solutions. This collaboration will embed agentic AI and Copilot, utilizing Foundry IQ, Work IQ, and Fabric IQ capabilities, into workflows to boost productivity and enhance customer experience. Additionally, Microsoft recently received a reiterated Buy rating and a $640 price target from Mizuho Securities analyst Gregg Moskowitz.

**4. Microsoft Corporation (MSFT) Expands AI Footprint With Major Partnerships and Cybercrime Platform Rollout**
- Source: Insider Monkey | 20251222T140849 | Somewhat-Bullish | Relevance: 64%
- Microsoft Corporation (MSFT) is expanding its AI initiatives with significant partnerships and new platform rollouts. The company confirmed the statewide deployment of MahaCrimeOS AI, an AI-powered platform for the Maharashtra police, leveraging Microsoft Azure OpenAI Service. Additionally, Microsoft announced partnerships with major IT firms like Cognizant, Infosys, TCS, and Wipro to integrate over 200,000 Copilot licenses, following a substantial $17.5 billion AI investment plan.

**5. Microsoft Corporation $MSFT Stock Position Lessened by Grant Private Wealth Management Inc**
- Source: MarketBeat | 20251221T103009 | Somewhat-Bullish | Relevance: 62%
- Grant Private Wealth Management Inc. significantly reduced its stake in Microsoft Corporation ($MSFT) by 37.9% in Q3, selling 5,317 shares and retaining 8,696 shares valued at approximately $4.50 million. In contrast, other large institutional investors like Vanguard Group, State Street, and Geode Capital Management increased their holdings in Microsoft during the same period. Despite some insider selling and concerns about capital expenditure mentioned by Jim Cramer, analysts maintain a "Moderate Buy" rating for MSFT, citing positive sentiment surrounding improving Azure AI margins, substantial investments in India, new enterprise partnerships, and participation in the U.S. AI "Genesis Mission."

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $82 | $78 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 18 ($0.00M) |
| Sells | 18 ($2.20M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.8%)
- Blackrock Inc.: 10.5% (-0.2%)
- JPMORGAN CHASE & CO: 8.2% (+108.3%)
- State Street Corpora: 5.2% (-0.9%)
- Pzena Investment Man: 3.7% (+1.5%)

### Key Risks

1. Elevated short interest (8.1%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.47 suggests fair value with growth premium. Forward P/E 15.2x stretched relative to 7% growth. Quality metrics strong (ROA 10%). Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.35), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +5%). Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.6B |
| Beta | 0.97 |
| 52W Range | $65.15 - $90.82 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.47 |
| Forward P/E | 15.2 |
| Current P/E | 16.2 |
| YoY Growth | 7.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 7.6% to 3.5% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.5pp (needs >4.0% for momentum thesis). MRS_5 (-0.9%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.5% shows strong absolute momentum above own 20MA. Outperforming sector by 3.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 80, risk of mean reversion. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.47% (CS: 83) | Neutral |
| RSI_14 | 80.1 | Overbought |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.133x | Above |
| vs SMA200 | 1.142x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $85.18
- **Stop Loss:** $81.68 (4.1% risk)
- **Target:** $92.18 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 342
- **Position Value:** $29,131.56
- **Portfolio %:** 29.13%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-04 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.39 | +6.7% |
| 2025Q2 | $1.26 | $1.31 | +4.0% |
| 2025Q1 | $1.20 | $1.23 | +2.5% |
| 2024Q4 | $1.13 | $1.21 | +7.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*